000			03314cam a2200397Mi 4500
001			94819
003			ES-MaUEC
005			20230102112633.0
006			m o d
007			cr nn|008mamaa
008			161031s2017 si a ob 000 0 eng d
020			_a9789811018787 _q(electronic bk.)
020			_a9811018782 _q(electronic bk.)
020			_z9789811018770 _q(print)
020			_z9811018774
035			_a(OCoLC)962018429 _z(OCoLC)961910210 _z(OCoLC)962009547 _z(OCoLC)974651535 _z(OCoLC)1005754701
040			_aAZU _cAZU _dOCLCO _dGW5XE _dIDEBK _dOCLCQ _dCOO _dOCLCF _dYDX _dN$T _dEBLCP _dUAB _dUPM _dIOG _dESU _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dVT2 _dU3W _dES-MaUEC _bspa
050		4	_aRM340 _b2017 EB
245	0	0	_aTreatment of non-vitamin K antagonist oral anticoagulants : _bfor prevention of stroke _cMasaaki Uno, Kuniaki Ogasawara, editors.
264		1	_aSingapore _bSpringer International Publishing
264		4	_c2017
300			_a1 recurso en línea (ix, 99 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
504			_aIncluye referencias bibliográficas
505	0		_a1. Intracranial Bleeding -- 2. Severity and Outcomes of Intracerebral Bleeding and Cardiac Cerebral Embolism -- 3. Influence for Intracranial Bleeding Surgery -- 4. New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-Vitamin K Antagonist Oral Anticoagulants -- 5. Secondary Prevention of Cerebral Infarct: Verification of Appropriateness in Choices of Anticoagulant by Comparison of Current and previous Treatment Results -- 6. Putaminal Hemorrhage in Patients with Oral Anticoagulants -Course of Treatment and Results of Endoscopic Evacuation -- 7. Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants -- 8. Causes and Outcome in Patients with Cerebral Hemorrhage Using Anticoagulated Drugs.
520	3		_aThis book describes new concepts and strategies for the clinical application of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke. Although vitamin K antagonists have traditionally been used for the prevention of stroke, there are some problems associated with their use, such as the risk of intracranial hemorrhage, the need for dietary restrictions, and individual variability. Recently, NOACs have been introduced as alternatives to traditional anticoagulants and are becoming an option for treating stroke patients around the globe. However, their use is not without risk. Each chapter describes the successful use of NOACs for stroke patients and discusses their future impact from various points of view. The book is primarily written for neurosurgeons and neurologists but is also of interest to cardiologists involved in stroke treatment.
650		7	_aAnticoagulantes _2embne _0(OCoLC)fst00810468 _0 _9144124
700	1		_aOgasawara, Kuniaki, _eeditor literario
700	1		_aUno, Masaaki, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-1878-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c94819 _d94819 _x1